March 05, 2019 FREMONT, Calif.–(BUSINESS WIRE)–Myoscience, a medical device company dedicated to relieving pain through targeted therapies, today announced that the company has entered into a definitive agreement for the acquisition of Myoscience by Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company dedicated to advancing and improving postsurgical outcomes for acute care practitioners and their patients. …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone